UK HealthCare logo

Practice areas

  • Gynecologic Cancer Team
  • Pediatric Hematology and Oncology Team
  • Radiation Medicine/Radiation Oncology

Faculty rank

Assistant Professor of Radiation Medicine

Clinic information

Clinical interests

  • Breast Cancer
  • Gynecologic Cancer
  • Pediatric Oncology
  • Radiation Oncology

Education

Degree

University of Kentucky College of Medicine, Lexington

Residency

University of Kentucky, Lexington

Certifications or Special training

American Board of Radiology, Radiation Oncology

Additional information

Profile

Jonathan M. Feddock received his medical degree from the UK College of Medicine in Lexington. His clinical interests include breast cancer, gynecologic cancer, pediatric oncology and radiation oncology.

He is an acting member of the Radiation Oncology committee for the Gynecologic Oncology Group (GOG) and NRG Oncology. Feddock also serves as chair of the Markey Cancer Center Research Audit Committee and is a member of the Data Safety and Monitoring Committee. He enrolls participants and serves as a site primary investigator for cooperative group trials, and he is the principal investigator for a Phase I trial for recurrent breast cancer.

His research interests include developing novel treatments for breast and gynecologic cancers, the development and education of Cesium-131 interstitial implants, narcotic/opiate abuse and dependency among cancer patients, and minimizing long-term toxicity from therapy in pediatric patients. He is actively involved with the Markey Cancer Foundation in fundraising. He also created and manages the Ironcology campaign, a unique fundraiser geared at combining his talents for racing Ironman-distance triathlons with cancer care.

Feddock is certified by the American Board of Radiology in Radiation Oncology.

Personal statement

One thing that makes me feel very passionate about my field is the fact that whenever we treat a patient, they're actually ours for about a period of six to eight weeks. I see these patients every single day, I get to know them and I get to know their families. I learn all about them, inside and out, and along the way I become a big part of their cancer journey and their cancer treatment, which is very unique compared to any other field in oncology.

Research/Publications

  1. Upreti M, Jyoti A, Johnson SE, Swindell EP, Napier D, Sethi P, Chan R, Feddock JM, Weiss HL, O'Halloran TV, Evers BM. Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer. Oncotarget. 2016 May 19.
    View in: PubMed
  2. Sethi P, Jyoti A, Swindell EP, Chan R, Langner UW, Feddock JM, Nagarajan R, O'Halloran TV, Upreti M. 3D tumor tissue analogs and their orthotopic implants for understanding tumor-targeting of microenvironment-responsive nanosized chemotherapy and radiation. Nanomedicine. 2015 Nov;11(8):2013-23.
    View in: PubMed
  3. Langner UW, Molloy JA, Gleason JF, Feddock JM. A feasibility study using TomoDirect for craniospinal irradiation. J Appl Clin Med Phys. 2013;14(5):104-14.
    View in: PubMed
  4. Seamon LG, Tarrant RL, Fleming ST, Vanderpool RC, Pachtman S, Podzielinski I, Branscum AJ, Feddock JM, Randall ME, Desimone CP. Cervical cancer survival for patients referred to a tertiary care center in Kentucky. Gynecol Oncol. 2011 Dec; 123(3):565-70. PMID: 21963092.
    View in: PubMed
  5. Shah PH, Kudrimoti M, Feddock J, Randall M. Adjuvant treatment for stage IIIC endometrial cancer: options and controversies. Gynecol Oncol. 2011 Sep; 122(3):675-83. PMID: 21664661.
    View in: PubMed
  6. Feddock J, Kudrimoti M, Randall M. No cookie-cutter oncology: individualized treatment approaches for women with corpus endometrial cancer. Expert Rev Anticancer Ther. 2010 Jul; 10(7):1087-100. PMID: 20645698.
    View in: PubMed